本页面由Tiger Trade Technology Pte. Ltd.提供服务

AbCellera Biologics

3.83
-0.0300-0.78%
盘后3.890.0600+1.57%19:53 EDT
成交量:291.19万
成交额:1,126.26万
市值:11.61亿
市盈率:-7.82
高:3.95
开:3.89
低:3.78
收:3.86
52周最高:6.52
52周最低:1.94
股本:3.03亿
流通股本:2.03亿
量比:1.07
换手率:1.44%
股息:- -
股息率:- -
每股收益(TTM):-0.4900
每股收益(LYR):-0.4902
净资产收益率:-14.47%
总资产收益率:-9.99%
市净率:1.20
市盈率(LYR):-7.81

数据加载中...

2022/07/06

重要事件披露

8-K - Current report
2022/06/30

重要事件披露

8-K - Current report
2022/06/21

重要事件披露

8-K - Current report
2022/05/10

重要事件披露

8-K - Current report
2022/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/24

重要事件披露

8-K - Current report
2022/02/15

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/07

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/12/07

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/22

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/15

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/09

重要事件披露

8-K - Current report